LLY

900.24

-0.63%↓

JNJ

240.4

+0.51%↑

ABBV

211.46

+2.44%↑

NVS

150.38

+0.61%↑

MRK

119.65

+0.73%↑

LLY

900.24

-0.63%↓

JNJ

240.4

+0.51%↑

ABBV

211.46

+2.44%↑

NVS

150.38

+0.61%↑

MRK

119.65

+0.73%↑

LLY

900.24

-0.63%↓

JNJ

240.4

+0.51%↑

ABBV

211.46

+2.44%↑

NVS

150.38

+0.61%↑

MRK

119.65

+0.73%↑

LLY

900.24

-0.63%↓

JNJ

240.4

+0.51%↑

ABBV

211.46

+2.44%↑

NVS

150.38

+0.61%↑

MRK

119.65

+0.73%↑

LLY

900.24

-0.63%↓

JNJ

240.4

+0.51%↑

ABBV

211.46

+2.44%↑

NVS

150.38

+0.61%↑

MRK

119.65

+0.73%↑

Search

Omnicell Inc

Fechado

SetorSaúde

35.2 0.77

Visão Geral

Variação de preço das ações

24h

Atual

Mín

34.07

Máximo

35.57

Indicadores-chave

By Trading Economics

Rendimento

-7.5M

-2M

Vendas

3.4M

314M

P/E

Médio do Setor

857.75

57.05

EPS

0.51

Margem de lucro

-0.645

Funcionários

3,580

EBITDA

-9.8M

21M

Recomendações

By TipRanks

Recomendações

Compra Forte

Previsão para 12 meses

+66.57% upside

Dividendos

By Dow Jones

Próximos Ganhos

5 de mai. de 2026

Estatísticas de Mercado

By TradingEconomics

Capitalização de Mercado

-678M

1.6B

Abertura anterior

34.43

Fecho anterior

35.2

Sentimento de Notícias

By Acuity

23%

77%

71 / 349 Ranking em Healthcare

Pontuação Técnica

By Trading Central

Confiança

Strong Bearish Evidence

Omnicell Inc Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Notícias Relacionadas

26 de mar. de 2026, 23:43 UTC

Conversa de Mercado

Nikkei May Decline Amid Uncertainty Over Iran Peace Talks -- Market Talk

26 de mar. de 2026, 23:36 UTC

Conversa de Mercado
Notícias Principais

Gold Rises Amid Signs of Easing Middle East Tensions -- Market Talk

26 de mar. de 2026, 23:35 UTC

Aquisições, Fusões, Aquisições de Empresas

Pernod Ricard: Confirms Discussions With Brown-Forman

26 de mar. de 2026, 23:29 UTC

Ganhos

Haier Smart Home: Company to Finance Share Buybacks Via Internal Funds >600690.SH

26 de mar. de 2026, 23:28 UTC

Ganhos

Haier Smart Home Plans A Share Buybacks of CNY3.0B-CNY6.0B >600690.SH

26 de mar. de 2026, 23:28 UTC

Ganhos

Haier Smart Home Plans to Increase Payout Ratio to 60% for 2027, 2028 >600690.SH

26 de mar. de 2026, 23:28 UTC

Ganhos

Haier Smart Home Plans Cash Dividend Payout Ratio of Up to 58% for 2026 >600690.SH

26 de mar. de 2026, 23:27 UTC

Ganhos

Haier Smart Home 2025 Net CNY19.55B Vs. Net CNY18.73B >600690.SH

26 de mar. de 2026, 23:27 UTC

Ganhos

Haier Smart Home 2025 Rev CNY302.33B Vs. CNY286.01B >600690.SH

26 de mar. de 2026, 23:08 UTC

Conversa de Mercado

Infratil's Investor Day Addresses Data-Center Issues -- Market Talk

26 de mar. de 2026, 23:04 UTC

Aquisições, Fusões, Aquisições de Empresas

Pernod Ricard in Talks to Combine With Jack Daniel's Maker Brown-Forman -- WSJ

26 de mar. de 2026, 23:04 UTC

Aquisições, Fusões, Aquisições de Empresas

Families Behind Pernod, Brown-Forman Would Each Likely Retain Significant Stakes, Source Says -- WSJ

26 de mar. de 2026, 23:04 UTC

Aquisições, Fusões, Aquisições de Empresas

Pernod, Brown-Forman Discussing Mostly Stock Deal, Source Says -- WSJ

26 de mar. de 2026, 23:04 UTC

Aquisições, Fusões, Aquisições de Empresas

Pernod-Brown-Forman Deal Announcement Could Be Weeks Away, Sources Say -- WSJ

26 de mar. de 2026, 23:04 UTC

Aquisições, Fusões, Aquisições de Empresas

Pernod in Deal Talks With Brown-Forman -- WSJ

26 de mar. de 2026, 22:41 UTC

Aquisições, Fusões, Aquisições de Empresas

Brown-Forman: No Agreement Has Been Reached as to Terms of Any Possible Pernod Ricard Transaction

26 de mar. de 2026, 22:41 UTC

Aquisições, Fusões, Aquisições de Empresas

Brown-Forman: Synergies From Contemplated Pernod Ricard Combination Expected to Be Significant

26 de mar. de 2026, 22:26 UTC

Ganhos

Jiangxi Copper 2025 Rev CNY544.62B Vs. CNY516.61B >0358.HK

26 de mar. de 2026, 22:26 UTC

Ganhos

Jiangxi Copper 2025 Net CNY7.13B Vs. Net CNY6.96B >0358.HK

26 de mar. de 2026, 22:26 UTC

Ganhos

Jiangxi Copper Higher Demand For Products Supported Results>0358.HK

26 de mar. de 2026, 22:08 UTC

Ganhos

Air China 2025 Loss CNY1.79B Vs. Loss CNY232.56M >0753.HK

26 de mar. de 2026, 22:08 UTC

Ganhos

Air China Impairment Loss on Goodwill Weighed on Results>0753.HK

26 de mar. de 2026, 22:08 UTC

Ganhos

Air China 2025 Rev CNY171.48B Vs. CNY166.70B >0753.HK

26 de mar. de 2026, 22:07 UTC

Conversa de Mercado
Notícias Principais

Global Energy Roundup: Market Talk

26 de mar. de 2026, 22:07 UTC

Conversa de Mercado
Notícias Principais

Open-Pit Gold Miners Most Exposed to High Fuel Prices -- Market Talk

26 de mar. de 2026, 22:00 UTC

Ganhos

Tsingtao Brewery 2025 Net CNY4.59B Vs. Net CNY4.34B >0168.HK

26 de mar. de 2026, 22:00 UTC

Ganhos

Tsingtao Brewery: Higher Volume Sales of Beer Supported Results>0168.HK

26 de mar. de 2026, 22:00 UTC

Ganhos

Tsingtao Brewery 2025 Rev CNY32.47B Vs. CNY32.14B >0168.HK

26 de mar. de 2026, 21:39 UTC

Aquisições, Fusões, Aquisições de Empresas

BlueScope: Sees Early Indications of Strong Interest in Site Adjacent Western Port

26 de mar. de 2026, 21:38 UTC

Aquisições, Fusões, Aquisições de Empresas

BlueScope: Has Begun Expression of Interest Process For 65-Hectare Site Adjacent Western Port

Comparação entre Pares

Variação de preço

Omnicell Inc Previsão

Preço-alvo

By TipRanks

66.57% parte superior

Previsão para 12 meses

Média 58.2 USD  66.57%

Máximo 70 USD

Mínimo 49 USD

Com base em 7 analistas de Wall Street que oferecem metas de preço de 12 meses para Omnicell Inc - Dist nos últimos 3 meses.

Consenso de Avaliação

By TipRanks

Compra Forte

7 ratings

6

Comprar

1

Manter

0

Vender

Pontuação Técnica

By Trading Central

24.23 / 30.44Suporte e Resistência

Curto Prazo

Strong Bearish Evidence

Médio Prazo

Strong Bearish Evidence

Longo Prazo

Bearish Evidence

Sentimento

By Acuity

71 / 349 Ranking em Saúde

Sentimento de Notícias

Evidência Muito Forte de Tendência de Alta

Volatilidade

Abaixo da média

Volume de Notícias (RCV)

Abaixo da média

Informação Financeira

Custos administrativos e de venda

Custos Operacionais

Lucro antes de imposto

Vendas

Custo das vendas

Lucro bruto sobre vendas

Despesa com juros da dívida

EBITDA

Resultado Operacional

$

Sobre Omnicell Inc

Omnicell, Inc., together with its subsidiaries, provides medication management solutions and adherence tools for healthcare systems and pharmacies the United States and internationally. The company offers point of care automation solutions to improve clinician workflows in patient care areas of the healthcare system; XT Series automated dispensing systems for medications and supplies used in nursing units and other clinical areas of the hospital, as well as specialized automated dispensing systems for operating room; and robotic dispensing systems for handling the stocking and retrieval of boxed medications. It also provides central pharmacy automation solutions; IV compounding robots; and inventory management software. In addition, the company provides single-dose automation solutions that fill and label a variety of patient-specific, single-dose medication blister packaging based on incoming prescriptions; fully automated and semi-automated filling equipment for institutional pharmacies to warrant automated packaging of medications; and medication blister card packaging and packaging supplies to enhance medication adherence in non-acute care settings. Further, it offers EnlivenHealth Patient Engagement, a web-based solutions. The company was formerly known as Omnicell Technologies, Inc. and changed its name to Omnicell, Inc. in 2001. Omnicell, Inc. was incorporated in 1992 and is headquartered in Fort Worth, Texas.
help-icon Live chat